mitoxantrone has been researched along with Plasma Cell Tumor in 2 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Engel, R | 1 |
Valkov, NI | 1 |
Gump, JL | 1 |
Hazlehurst, L | 1 |
Dalton, WS | 1 |
Sullivan, DM | 1 |
Wang, BS | 1 |
Ruszala-Mallon, V | 1 |
Wallace, RE | 1 |
Citarella, RV | 1 |
Lin, YI | 1 |
Durr, FE | 1 |
2 other studies available for mitoxantrone and Plasma Cell Tumor
Article | Year |
---|---|
The cytoplasmic trafficking of DNA topoisomerase IIalpha correlates with etoposide resistance in human myeloma cells.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Blotting, Wes | 2004 |
Modulation of the immune response to tumors by a novel synthetic compound, N-[4-[(4-fluorophenyl)sulfonyl]phenyl] acetamide (CL 259,763).
Topics: Adjuvants, Immunologic; Animals; Anthraquinones; Antineoplastic Agents; Cell Line; Colony-Stimulatin | 1986 |